Download PDF
Eur J Pediatr Surg 2017; 27(04): 313-318
DOI: 10.1055/s-0036-1592137
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Positive Oct -3/4 and D2–40 Immunohistochemical Expression in Germ Cells and Suspected Histology Pattern of Intratubular Germ Cell Neoplasia in Boys with Cryptorchidism Vanish after the Age of 2 Years

Jorgen Thorup
1   Department of Pediatric Surgery, Rigshospitalet, Copenhagen, Denmark
2   Institute for Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Denmark
,
Erik Clasen-Linde
3   Department of Pathology, Rigshospitalet, Copenhagen, Denmark
,
Dina Cortes
1   Department of Pediatric Surgery, Rigshospitalet, Copenhagen, Denmark
2   Institute for Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Denmark
4   Section of Endocrinology, Department of Pediatrics, Hvidovre Hospital, Copenhagen, Denmark
› Author Affiliations
Further Information

Publication History

10 March 2016

21 July 2016

Publication Date:
08 September 2016 (online)

    Permissions and Reprints

Abstract

Introduction Intratubular germ cell neoplasia (ITGCN) is a precursor to testicular germ cell cancer. Adult germ cell cancer immunohistochemical markers may fail to detect ITGCN in prepubertal boys with congenital cryptorchidism, because positive immunohistochemistry is commonly seen in boys younger than the age of 2 years, where most orchiopexies are performed. The aim of the study was to evaluate the diagnostic challenge to differentiate between a histological pattern of ITGCN and a histological pattern with some atypical germ cells and all positive cancer immunohistochemical markers, but no increased risk of malignancy.

Materials and Methods Histology sections from 373 testicular biopsies from 289 boys aged 1 month to 2 years operated for cryptorchidism were incubated with primary antibodies including anti-placental-like-alkaline phosphatase, antiOct-3/4, anti-C-kit, anti-D2–40, and in case of repeat biopsy with anti-stem cell factor (SCF) receptor.

Results The prevalence of Oct-3/4 and D2–40-positive staining of germ cells in testicular biopsies were in age groups less than 6 months, 100% and 50%; 6–12 months, 60% and 17%; and 1–2 years, 12% and 4%. A 1 year, 1-month-old boy with Prader–Willi syndrome treated with growth hormone had ITGCN in both cryptorchid testes. In another three bilateral nonsyndromic cases, 8 months, 8 months and 1-year-old, a histological pattern in accordance with ITGCN was found. These three boys had a repeat biopsy from both testes performed at the age of 3 years, 4 months, 3.5 years, and 3 years, 10months, respectively. In all cases, the Oct-3/4 and D2–40 positive germ cells turned negative and the histological pattern normalized completely. The primary biopsies had SCF negative germ cells.

Conclusion This study is valuable in identifying the age-related change in Oct-3/4 or D2–40 immunopositive germ cells in seminiferous tubules. An ITGCN-like histological pattern in nonsyndromic cryptorchidism will vanish after the age of 3 years. Even when immunohistochemistry is applied, prepubertal ITGCN is so rarely demonstrated in cryptorchid testes, that it is not plausible that ITGCN generally originates during fetal development in cryptorchidism.

Keywords

testicular neoplasia - cryptorchidism - immunohistochemistry
 

  • References

  • 1 Cortes D. Cryptorchidism—aspects of pathogenesis, histology and treatment. Scand J Urol Nephrol Suppl 1998; 196: 1-54
    PubMedGoogle Scholar
  • 2 Kvist K, Clasen-Linde E, Cortes D, Petersen BL, Thorup J. Adult immunohistochemical markers fail to detect intratubular germ cell neoplasia in prepubertal boys with cryptorchidism. J Urol 2014; 191 (04) 1084-1089
    CrossrefPubMedGoogle Scholar
  • 3 Kolon TF, Herndon CD, Baker LA. , et al; American Urological Assocation. Evaluation and treatment of cryptorchidism: AUA guideline. J Urol 2014; 192 (02) 337-345
    CrossrefPubMedGoogle Scholar
  • 4 Thorup J, Kvist K, Clasen-Linde E, Petersen BL, Cortes D. The relation between adult dark spermatogonia and other parameters of fertility potential in cryptorchid testes. J Urol 2013; 190 (4, Suppl): 1566-1571
    CrossrefPubMedGoogle Scholar
  • 5 Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006; 12 (03) 303-323
    CrossrefPubMedGoogle Scholar
  • 6 Kristensen DG, Skakkebaek NE, Rajpert-De Meyts E, Almstrup K. Epigenetic features of testicular germ cell tumours in relation to epigenetic characteristics of foetal germ cells. Int J Dev Biol 2013; 57 (2–4): 309-317
    CrossrefPubMedGoogle Scholar
  • 7 Hersmus R, Stoop H, White SJ. , et al. Delayed recognition of disorders of sex development (DSD): a missed opportunity for early diagnosis of malignant germ cell tumors. Int J Endocrinol 2012; 2012: 671209
    PubMedGoogle Scholar
  • 8 Clasen-Linde E, Kvist K, Cortes D, Thorup J. The value of positive Oct3/4 and D2-40 immunohistochemical expression in prediction of germ cell neoplasia in prepubertal boys with cryptorchidism. Scand J Urol 2016; 50 (01) 74-79
    PubMedGoogle Scholar
  • 9 Stoop H, Honecker F, van de Geijn GJM. , et al. Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol 2008; 216 (01) 43-54
    CrossrefPubMedGoogle Scholar
  • 10 Ritzén EM, Bergh A, Bjerknes R. , et al. Nordic consensus on treatment of undescended testes. Acta Paediatr 2007; 96 (05) 638-643
    CrossrefPubMedGoogle Scholar
  • 11 Cortes D, Thorup JM, Visfeldt J. Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm Res 2001; 55 (01) 21-27
    PubMedGoogle Scholar
  • 12 Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004; 203 (03) 849-857
    CrossrefPubMedGoogle Scholar
  • 13 Satgé D, Sasco AJ, Curé H, Leduc B, Sommelet D, Vekemans MJ. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature. Cancer 1997; 80 (05) 929-935
    CrossrefPubMedGoogle Scholar
  • 14 Hawkins E, Heifetz SA, Giller R, Cushing B. The prepubertal testis (prenatal and postnatal): its relationship to intratubular germ cell neoplasia: a combined Pediatric Oncology Group and Children's Cancer Study Group. Hum Pathol 1997; 28 (04) 404-410
    CrossrefPubMedGoogle Scholar
  • 15 Looijenga LHJ, Stoop H, de Leeuw HPJ. , et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63 (09) 2244-2250
    PubMedGoogle Scholar
  • 16 Hadziselimovic F, Emmons LR, Buser MW. A diminished postnatal surge of Ad spermatogonia in cryptorchid infants is additional evidence for hypogonadotropic hypogonadism. Swiss Med Wkly 2004; 134 (25–26): 381-384
    PubMedGoogle Scholar
  • 17 Sonne SB, Herlihy AS, Hoei-Hansen CE. , et al. Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch 2006; 449 (02) 200-206
    CrossrefPubMedGoogle Scholar
  • 18 Hadziselimović F, Thommen L, Girard J, Herzog B. The significance of postnatal gonadotropin surge for testicular development in normal and cryptorchid testes. J Urol 1986; 136 (1 Pt 2): 274-276
    CrossrefPubMedGoogle Scholar
  • 19 Hutson JM, Li R, Southwell BR, Petersen BL, Thorup J, Cortes D. Germ cell development in the postnatal testis: the key to prevent malignancy in cryptorchidism?. Front Endocrinol (Lausanne) 2012; 3: 176
    PubMedGoogle Scholar
  • 20 Setchell BP. The Parkes Lecture. Heat and the testis. J Reprod Fertil 1998; 114 (02) 179-194
    CrossrefPubMedGoogle Scholar
  • 21 Zini A, Abitbol J, Schulsinger D, Goldstein M, Schlegel PN. Restoration of spermatogenesis after scrotal replacement of experimentally cryptorchid rat testis: assessment of germ cell apoptosis and eNOS expression. Urology 1999; 53 (01) 223-227
    CrossrefPubMedGoogle Scholar
  • 22 Ivell R, Hartung S. The molecular basis of cryptorchidism. Mol Hum Reprod 2003; 9 (04) 175-181
    CrossrefPubMedGoogle Scholar
  • 23 Hanna NH, Einhorn LH. Testicular cancer—discoveries and updates. N Engl J Med 2014; 371 (21) 2005-2016
    CrossrefPubMedGoogle Scholar
  • 24 Giwercman A, Bruun E, Frimodt-Møller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989; 142 (04) 998-1001 , discussion 1001–1002
    CrossrefPubMedGoogle Scholar
  • 25 Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 2007; 356 (18) 1835-1841
    CrossrefPubMedGoogle Scholar
  • 26 Cools M, Pleskacova J, Stoop H. , et al; Mosaicism Collaborative Group. Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab 2011; 96 (07) E1171-E1180
    CrossrefPubMedGoogle Scholar